Methods
A total of 77 patients underwent VIV-TAVR for failing aortic
bioprosthesis during a 7-years period. Predominant mode of failure was
stenosis in 87.0%. Patients had a mean age of 79.4±5.8 years and a mean
logistic EuroSCORE of 30.8±15.7%. The STS-PROM averaged 5.79±2.63%.
Clinical results and hemodynamic outcomes are reported for 30-days, 1-,
2- and 3-years. Completeness of follow-up was 100% with 44 patients at
risk after 3-years. Follow-up ranged up to 7.1 years.